Alejandro Aballay, Ph.D.The Department of Molecular Microbiology & Immunology comprises a cadre of interactive and interdisciplinary faculty with diverse expertise. The overall mission of our department involves research and education, while bringing together basic and translational efforts through close collaborations.
-Alejandro Aballay, Ph.D.

MMI Recognitions

Congratulations to the following recipients of awards and recognitions!

Amanda Lund, Ph.D., awarded the V Foundation for Cancer Research Award for her project, Lymphatic Vessel, PD-L1 and Anti-Tumor Immunity.

Erin Meermeier, awarded the 2015 Sears Fellowship Award for $2,000 for Human MR1-restricted T cells expressing TRAV12-2 display enhanced microbial discrimination.

Amanda Lund, Ph.D., for being awarded the Discovery Award for Women in Science by the Women in Academic Medicine Committee.

Mary Stenzel-Poore, Ph.D., grant awarded for STTR – Identifying activators of interferon regulatory factors for neuroprotection.

Tim Nice, Ph.D., awarded the Collins Medical Trust for his project, Type I/III interferons in mucosal immunity to enteric viral infection.

Scott Landfear, Ph.D., grant awarded for NIH/NIAID, RO1 – Function of the Essential KHARON1 Protein in Bloodstream Form African Trypanosomes.

Helen Wu, for receiving an F31 award (individual NRSA). 

MMI News

Welcome to our new chair

The Department of Molecular Microbiology & Immunology welcomes Alejandro Aballay, Ph.D.! 

Alejandro Aballay, Ph.D.We are excited to have Dr. Aballay join MMI as our new department chair, as of September 2017.  We look forward to opportunity and growth ahead. Welcome! 

Please read the School of Medicine announcement here

Welcome to our new faculty

Fikadu TafesseWe are delighted to announce Fikadu Tafesse, Ph.D., as an Assistant Professor in the Department of Molecular Microbiology & Immunology, as of February 2016. Fikadu comes from Ragon Institute of Massachusetts General Hospital, MIT and Harvard. His research goals are directed toward understanding how pathogens - mainly Mycobacterium tuberculosis - utilize host cellular processes during infection and ways to harness these mechanisms to develop therapeutic strategies to counteract diseases. His post-doctoral work in the lab of Hidde Ploegh at the Whitehead Institute of MIT aimed at identification and characterization of host factors including the various host metabolites/lipids during infections of influenza virus, bacterial toxins and the pathogenic fungi C. albicans. Originally from Ethiopia, Fikadu was drawn to working on M. tuberculosis because it is endemic in that region of the world.

Tim NiceWe are excited to to welcome Tim Nice, Ph.D., to the Department of Molecular Microbiology & Immunology. He is joining OHSU from the completion of a postdoctoral fellowship in the laboratory of Dr. “Skip” Virgin at Washington University School of Medicine, where he established the murine norovirus (MNoV) model of persistent enteric viral infection. 

Noroviruses and other enteric viruses are a major public health burden worldwide. Dr. Nice is using this MNoV model system to identify a role for interferon lambda (IFNλ) in innate immune control and clearance of persistent MNoV infection. His research will focus specifically on defining innate immune mechanisms by which IFNλ clears persistent MNoV infection, and more broadly on host-microbe interactions that regulate viral infection and shedding at mucosal surfaces.

A warm welcome to our newest faculty members!